News on Boulder Ventures%2C Ltd. from BioPortfolio.com http://www.BioPortfolio.com Consolidated Boulder Ventures%2C Ltd. news from BioPortfolio.com Wed, 10 Feb 2010 12:09:32 GMT en Sofinnova Partners: Sofinnova Partners Completes Exit to Tyco Ele...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970648&HITNO=0&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970648&THISHREF=http://c.moreover.com/click/here.pl%3fz2501436144%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970648&HITNO=0&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970648&THISHREF=http://c.moreover.com/click/here.pl%3fz2501436144%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: mTouche plans to divest GMO stakehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961425&HITNO=1&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961425&THISHREF=http://c.moreover.com/click/here.pl%3fz2496758312%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961425&HITNO=1&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961425&THISHREF=http://c.moreover.com/click/here.pl%3fz2496758312%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Times Malaysia: BRIEF: Biotech co Proteologics looks to TASE offering: Proteologics has joint drug development programs with Thttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959394&HITNO=2&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959394&THISHREF=http://c.moreover.com/click/here.pl%3fz2495750331%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959394&HITNO=2&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959394&THISHREF=http://c.moreover.com/click/here.pl%3fz2495750331%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Biotech co Proteologics looks to TASE offeringhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957956&HITNO=3&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957956&THISHREF=http://c.moreover.com/click/here.pl%3fz2495160675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957956&HITNO=3&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957956&THISHREF=http://c.moreover.com/click/here.pl%3fz2495160675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobes: BRIEF: Root canal co ReDent Nova gets FDA nod: The Maayan Ventures portfolio firm claims its device saves up to 50% of treatment time.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923093&HITNO=4&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923093&THISHREF=http://c.moreover.com/click/here.pl%3fz2476376874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923093&HITNO=4&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923093&THISHREF=http://c.moreover.com/click/here.pl%3fz2476376874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: BRIEF: Root canal co ReDent Nova gets FDA nod: The Maayan Ventures portfolio firm claims its device saves up thttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3921953&HITNO=5&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3921953&THISHREF=http://c.moreover.com/click/here.pl%3fz2475535317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3921953&HITNO=5&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3921953&THISHREF=http://c.moreover.com/click/here.pl%3fz2475535317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Goldbrook Confirms Delisting of Canadian Royaltieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3916433&HITNO=6&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3916433&THISHREF=http://c.moreover.com/click/here.pl%3fz2471878696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3916433&HITNO=6&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3916433&THISHREF=http://c.moreover.com/click/here.pl%3fz2471878696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Cash Minerals Appoints Doug Currie President & Chief Executive Officerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3913234&HITNO=7&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3913234&THISHREF=http://c.moreover.com/click/here.pl%3fz2470588883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3913234&HITNO=7&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3913234&THISHREF=http://c.moreover.com/click/here.pl%3fz2470588883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Covalon Announces New Board Membershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912760&HITNO=8&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912760&THISHREF=http://c.moreover.com/click/here.pl%3fz2470354399%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912760&HITNO=8&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912760&THISHREF=http://c.moreover.com/click/here.pl%3fz2470354399%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Funxional Therapeutics Announces Successful Completion of the Phase I Programme of its Novel Anti-inflammatoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3887887&HITNO=9&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3887887&THISHREF=http://c.moreover.com/click/here.pl%3fz2458227381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3887887&HITNO=9&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3887887&THISHREF=http://c.moreover.com/click/here.pl%3fz2458227381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioPortfolio: Funxional Therapeutics Announces Successful Completion of the Phase I Programme of its Novel Anti-inflammatoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877640&HITNO=10&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877640&THISHREF=http://c.moreover.com/click/here.pl%3fz2452000886%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877640&HITNO=10&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877640&THISHREF=http://c.moreover.com/click/here.pl%3fz2452000886%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Funxional Therapeutics Announces Successful Completion of the Phase I Programme of Its Novel Anti-Inflammatoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877474&HITNO=11&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877474&THISHREF=http://c.moreover.com/click/here.pl%3fz2451946200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877474&HITNO=11&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877474&THISHREF=http://c.moreover.com/click/here.pl%3fz2451946200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Notal Vision gets FDA nod for AMD home diagnostic kithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3871065&HITNO=12&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3871065&THISHREF=http://c.moreover.com/click/here.pl%3fz2449042975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3871065&HITNO=12&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3871065&THISHREF=http://c.moreover.com/click/here.pl%3fz2449042975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobes: Notal Vision gets FDA approval for eye disease home diagnostic kithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870951&HITNO=13&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870951&THISHREF=http://c.moreover.com/click/here.pl%3fz2448985346%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870951&HITNO=13&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870951&THISHREF=http://c.moreover.com/click/here.pl%3fz2448985346%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobes: Acquisition of AkaRx by Eisai for $255M Closeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869084&HITNO=14&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869084&THISHREF=http://c.moreover.com/click/here.pl%3fz2448096754%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869084&HITNO=14&MSIZE=23&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Boulder%20Ventures,%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869084&THISHREF=http://c.moreover.com/click/here.pl%3fz2448096754%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: